Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-09-08
2000-07-11
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
A61K 3170
Patent
active
06087340&
ABSTRACT:
A sealed glass container containing therein a stable, injectable, sterile, pyrogen-free doxorubicin anti-tumor composition in a solution which consists essentially of a physiologically acceptable salt of doxorubicin dissolved in a physiologically acceptable solvent therefor, wherein said solution has not been reconstituted from a lyophilizate, and wherein said solution has a pH of from 2.5-3.5 and a concentration of said doxorubicin of from 0.1 to 100 mg/ml.
REFERENCES:
patent: 3686163 (1972-08-01), Arcamrone et al.
patent: 4035566 (1977-07-01), Israel et al.
patent: 4039633 (1977-08-01), Zelinski
patent: 4039663 (1977-08-01), Arcamyone et al.
patent: 4039736 (1977-08-01), Rettleton, Jr. et al.
patent: 4109076 (1978-08-01), Henry et al.
patent: 4296105 (1981-10-01), Baurain et al.
patent: 4327087 (1982-04-01), Rosenkrantz et al.
patent: 4537593 (1985-08-01), Alchas
patent: 4564054 (1986-01-01), Gustavsson
patent: 4576211 (1986-03-01), Valentini et al.
patent: 4588403 (1986-05-01), Weiss et al.
patent: 4786281 (1988-11-01), Valentini et al.
patent: 4946831 (1990-08-01), Gatti et al.
Kano et al., Electrochemical Properties of Adriamycin Adsorbed on a Mercury Electrode Surface, The Chemical Society of Japan, Bull. Chem. Soc. Jpn., 57, 2383-2390 (1984).
Kano et al., The Effects of the pH and the Temperature on the Oxidation-reduction Properties of Adriamycin Adsorbed on a Mercury Electrode Surface, The Chemical Society of Japan, Bull. Chem. Soc. Jpn., 58, 424-428 (1985).
Beijnen et al. (1985), "Stability of Anthracycline Antitumor Agents in Infusion Fluids," J. Parenteral Science and Technology, vol. 39, pp 220-222.
Beijnen et al. (1986), "Aspects of Degradation Kinetics of Daunorubicin in Aqueous Solution," International J. Pharmaceutics, vol. 31, pp. 75-82.
Beijnen et al. (1986), "Aspects of the Degradation Kinetics of Doxorubicin in Aqueous Solution," International J. Of Pharmaceutics, vol. 32, pp. 123-131.
Bosanquet, A.G. (1986), "Stability of Solutions of Antineoplastic Agents During Preparation and Storage For In Vitro Assays," Cancer Chemother. Pharmacol., vol. 17, pp. 1-10.
Daugherty et al. (1981), "Photolytic Destruction of Adriamycin," J. Pharm. Pharmacol., vol. 33, p. 556.
Dorr and Fritz (1980), "Doxorubicin," Cancer Chemotherapy Handbook, Elsevier, New York, pp. 388-401.
Eksborg and Ehrsson (1984), "Liquid Chromatography in Anticancer Drug Research with Special Reference to Anthraquinone Glycosides," J. Pharmaceutical & Biomedical Analysis, vol. 2, pp. 297-303.
Eksborg, S. (1978), "Extraction of Daunorubicin and Doxorubicin and Their Hydrox Metabolities: Self-Association in Aqueous Solution," J. Pharmaceutical Sciences, vol. 67, pp. 782-785.
Flora et al. (1980), "The Loss of Paraben Preservatives During Freeze Drying," J. Pharm. Pharmacol., vol. 32, pp. 577-578.
Florence and Atwood (1981), "Physicochemial Principles of Pharmacy" MacMillan Press, London, p. 475.
Garnick et al. (1983), "Clinical Evaluation of Long-Term, Continuous-Infusion Doxorubicin," Cancer Treatment Reports, vol. 67, pp. 133-142.
Henry, D. W. (1976), "Adriamycin," Cancer Chemotherapy, American Chemical Society Symposium Series, pp. 15-57.
Hoffman et al. (1979) "Stability of Refrigerated and Frozen Solutions of Doxorubicin Hydrochloride," Am. J. Hosp. Pharm., vol. 36, 1536-1538.
Janssen et al. (1985), "Doxorubicin Decomposition on Storage. Effect of pH, Type of Buffer and liposome Encapsulation," International J. Pharmaceutics, vol. 23, pp. 1-11.
Kaniewska, T. (1978), "Study of the Decomposition of Adriamycin," Chemical Abstracts, vol. 88, No. 197526x, p. 396.
Kaniewska, T. (1977), "A Study of Decomposition of Adriamycin," Pharmacia Polska, vol. 9, 539-542 (English translation attached).
Ketchum et al. (1981), "Cost Benefit and Stability Study of Doxorubicin Following Reconstitution," Am. J. Intravenous Therapy & Clinical Nutrition, vol. 8, pp. 15-18.
Kristensen and Moller (1983), "Alman Farmaci II," Dansk Farmaceutforeings Forlag Kobenhavn, pp. 408, 442, 447 (English translation attached).
Martindale (1982), "Doxorubicin Hydrochloride," The Extra Pharmacopeia, Antineoplastic Agents and Immunosuppressants, 28th Edition, The Pharmaceutical Press, London, J.E.F. Reynolds, Ed., pp. 205-208.
Masuike et al. (1984), "Determination of Adriamycin and Its Metabolites in Biological Samples Using High Performance Liquid Chromatograhy. I. Analysis of Serum and Plasma by Direct Injection Method," Yakugaku Zasshi, vol. 104, 614-619 (English abstract).
Masuike et al. (1984), "Determination of Adriamycin and Its Metabolites in Biological Samples Using High Performance Liquid Chromatograhy. II. Analysis of Tissues by Extraction Method," Yakugaku Zasshi, vol. 104, 620-623 (English abstract).
Menozzi et al. (1984), "Self-Association of Doxorubicin and Related Compounds in Aqueous Solution," J. Pharmaceutical Sciences, vol. 73, pp. 766-770.
Poochikian et al. (1981), "Stability of Anthracycline Antitumor Agents in Four Infusion Fluids," Am. J. Hospital Pharmacy, vol. 38, pp. 483-486.
Savlov et al. (1981), "Comparison of Doxoorubicin with Cycloleucine in the Treatment of Sarcomas," Cancer Treatment Reports, vol. 65, pp. 21-27.
Trissell (1980), "Doxorubicin HCI," Handbook of Injectable Drugs, Third Ed. (American Society of Hospital Pharmacists, Bethesda, MD), pp. 131-132.
Vigevani and Williamson (1980), "Doxorubicin," In Analytical Profiles of Drug Substances, Academic Press, New York, vol. 9, pp. 245-263, 246-274.
Williamson et al. (1983), "Doxorubicin Hydrochloride-Aluminum Interaction," Am. J. Hospital Pharmacy, vol. 40, p. 214.
Yu-Chang et al. (1980), "Review of Excipients and pH's for Parenteral Products Used in the United States," J. Parenteral Drug. Assoc., vol. 14, pp. 452-462.
Chemistry Industry, "Union Warns of Cancer Drug Dangers," Issue Jul. 4, 1983, p. 488.
Drug Topics, "Cancer Drug Danger," Feb. 7, 1983, p. 99.
Gutteridge and Wilkins (1983), "Doxorubicin Degradation: Changes in Activity Compared by Bacterial Growth Inhibition and Free Radical-Dependent Damage to Deoxyribose," J. Biological Standardization, vol. 11, pp. 359-364.
Akbiyik et al. (1979), "Total Lung Irradiation and Chemotheraphy in Pulmonary Metastases from Carcinoma of the Uterine Cervix and Endometrium," J. Nat'l Medical Assn., vol. 71, pp. 1061-1063.
The Pharmaceutical Codex (1979), "Injections," The Pharmaceutical Press, London, 11th Edition, pp. 446-447.
Swinyard, E.A. (1980), "Introduction of New Drugs," Pharmaceutical Sciences, Mack Publishing Co., Easton, Pennsylvania, pp. 1365-1376.
The Merck Index (1983), "Doxorubicin," 10th Edition, Entry 3435, p. 3436.
Nikula et al. (1984), "Chromosome Aberrations in Lymphocytes of Nurses Handling Cytostatic Agents," Scand. J. Work Environ. Health, vol. 10, pp. 71-74.
U.S. Pharmacopoeia, "Doxorubicin Hydrochloride for Injection," 20th revision, p. 266.
U.S. Pharmacopoeia (1985), p. 119.
Formularium Der Nederlandse Apoethekers, Band V. (1983), p. I.8 I.24, I63-I.64a, I.82, I.88.
Yoo (1977), Section "Injections" in the Korean Pharmacopoeia, pp. 3, 48-49.
Harris, D. C. (1995), Quantitative Chemical Analysis, Fourth Edition, W.H. Freeman & Company, New York, pp. 234-241.
Jonkman-de Vries et al. (1994), "Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Indoloquinone Antitumor Agentd EO9," Cancer Chemother.Pharmacol., vol. 34, pp. 416-422.
The Merck Index (1989), "Hydrochloric Acid," S. Budavari, Ed., Merck & Co., Inc., Rahway, New Jersey, No. 4703, p. 756.
The Merck Index (1989), "Aclacinomycins," S. Budavari, Edl, Merck & Co., Inc., Rahway, New Jersey, No. 108, p. 17.
Trissel, L.A. (1983), "Investigational Drugs," Handbook on Injectable Drugs, Third Edition, American Society of Hospital Pharmacists.
The Merck Index (1983), "Doxorubicin," 10th Edition, AN-3435, p. 499.
Europaischez Arzneibuch, vol. III, 1979, p. 654 (English translation attached).
Arcamone et al. (1972), "Structure and Physiochemical Properties of Adriamycin (Doxorubicin)," International Symposium on Adriamycin, Springer-Verlag, Berlin, pp. 9-22.
Beijnen, J.H. et al. (1985), "Aspects of the Chemical Stability
Bottoni Giuseppe
Confalonieri Carlo
De Ponti Roberto
Gambini Luciano
Gatti Gaetano
Peselev Elli
Pharmacia & Upjohn, Inc.
LandOfFree
Injectable ready-to-use solutions containing an antitumor anthra does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable ready-to-use solutions containing an antitumor anthra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable ready-to-use solutions containing an antitumor anthra will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-542523